Disseminated peritoneal leiomyomatosis

Summary

Disseminated peritoneal leiomyomatosis (MONDO:0006183) is a disease and 1 clinical trial. A subtype of peritoneal benign neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
• Clinical trials: 1

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

Type	Class	Value	Geography	Validation
Cases/families		150	Worldwide	Validated
Point prevalence	<1 / 1 000 000		Worldwide	Validated

Identifiers

Disease identifiers

Field	Value
Canonical name	disseminated peritoneal leiomyomatosis
Mondo ID	MONDO:0006183
EFO	EFO:1000220
Orphanet	71274
DOID	DOID:5728
NCIT	C3958
SNOMED CT	62557001
UMLS	C0267785
MedGen	78634
GARD	0012843
Is cancer (heuristic)	no

Also known as: diffuse peritoneal leiomyomatosis · disseminated peritoneal leiomyomatosis · DPL · leiomyomatosis peritonealis disseminata · leiomyomatosis peritonealis disseminate · LPD

Disease family

This is a subtype of peritoneal benign neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › benign neoplasm › peritoneal benign neoplasm › disseminated peritoneal leiomyomatosis

Related subtypes (2): benign peritoneal mesothelioma, benign peritoneal solitary fibrous tumor

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT02834169	Not specified	UNKNOWN	French National Registry of Rare Peritoneal Surface Malignancies